ciprofloxacin has been researched along with posaconazole in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kochanek, M; Michels, G; Pfister, R; Shimabukuro-Vornhagen, A | 1 |
Endy, TP; Nat, A; Rane, M; Sharma, AM; Sharma, N | 1 |
1 review(s) available for ciprofloxacin and posaconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for ciprofloxacin and posaconazole
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[53-year-old woman with life-threatening complications after use of ciprofloxacin and posaconazol].
Topics: Anti-Infective Agents; Cardiopulmonary Resuscitation; Ciprofloxacin; Electrocardiography; Female; Humans; Leukemia; Long QT Syndrome; Middle Aged; Risk Factors; Triazoles | 2012 |
Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Mycetoma; Triazoles; Young Adult | 2014 |